One Stop Shop for All Your Market Research Reports

Global Rosuvastatin Calcium Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke.Rosuvastatin calcium is a hygroscopic powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal dissolution can be obtained (depending on formulation). Rosuvastatin Calcium is a member of the drug class of statins, used in combination with exercise, diet, and weight-loss to treat high cholesterol and related conditions, and to prevent cardiovascular disease. It works by slowing the production of cholesterol in the body to decrease the amount of cholesterol that may build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body. Rosuvastatin Calcium was developed by Shionogi and has been formulated into finished oral dosage form and marketedby AstraZeneca as Crestor, Abbott Laboratories as R2. According to our (Global Info Research) latest study, the global Rosuvastatin Calcium market size was valued at USD 540.9 million in 2022 and is forecast to a readjusted size of USD 703.6 million by 2029 with a CAGR of 3.8% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. In additional, EU is also the largest consumer of rosuvastatin calcium, about 34% of the global production was consumed in EU. China is the second producer with the market share of 28%. Top Three manufacturers in rosuvastatin calcium are AstraZeneca, MSN Laboratories, Changzhou Pharmaceutical Factory, according for 55% of the total amount. This report is a detailed and comprehensive analysis for global Rosuvastatin Calcium market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided. Key Features: Global Rosuvastatin Calcium market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2018-2029 Global Rosuvastatin Calcium market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2018-2029 Global Rosuvastatin Calcium market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2018-2029 Global Rosuvastatin Calcium market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (USD/Kg), 2018-2023 The Primary Objectives in This Report Are: To determine the size of the total market opportunity of global and key countries To assess the growth potential for Rosuvastatin Calcium To forecast future growth in each product and end-use market To assess competitive factors affecting the marketplace This report profiles key players in the global Rosuvastatin Calcium market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Teva Pharmaceutical Industries, MSN Laboratories, Cadila Pharmaceuticals and LGM Pharma, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence. Market Segmentation Rosuvastatin Calcium market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets. Market segment by Type Purity 98.0% Purity 99.0% Other Market segment by Application Tablet (including dispersible tablet and general tablet) Capsule Others Major players covered AstraZeneca Teva Pharmaceutical Industries MSN Laboratories Cadila Pharmaceuticals LGM Pharma Bal Pharma Changzhou Pharmaceutical Factory Jingxin Pharm Zhejiang Hisun Pharmaceutical HEC Pharm Lunan Pharmaceutical Nanjing Frochem Tech Lianyungang Runzhong Pharmaceutical Shandong Bechem Chemicals CTX Life Sciences Market segment by region, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia) South America (Brazil, Argentina, Colombia, and Rest of South America) Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa) The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Rosuvastatin Calcium product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top manufacturers of Rosuvastatin Calcium, with price, sales, revenue and global market share of Rosuvastatin Calcium from 2018 to 2023. Chapter 3, the Rosuvastatin Calcium competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Rosuvastatin Calcium breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029. Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029. Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Rosuvastatin Calcium market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029. Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War. Chapter 13, the key raw materials and key suppliers, and industry chain of Rosuvastatin Calcium. Chapter 14 and 15, to describe Rosuvastatin Calcium sales channel, distributors, customers, research findings and conclusion.
1 Market Overview 1.1 Product Overview and Scope of Rosuvastatin Calcium 1.2 Market Estimation Caveats and Base Year 1.3 Market Analysis by Type 1.3.1 Overview: Global Rosuvastatin Calcium Consumption Value by Type: 2018 Versus 2022 Versus 2029 1.3.2 Purity 98.0% 1.3.3 Purity 99.0% 1.3.4 Other 1.4 Market Analysis by Application 1.4.1 Overview
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3480
Multi User US $5220
Corporate User US $6960
About this Report
Report ID 29032
Category
  • Pharmaceuticals and Healthcare
Published on 03-Jan
Number of Pages 117
Publisher Name Global Info Research
Editor Rating
★★★★★
★★★★★
(21)